Meningitis Deaths Prompt FDA to Seek Pharmacy Oversight

The top U.S. drug regulator asked Congress for more authority over pharmacies following the deadly meningitis outbreak, a request met with resistance by lawmakers who said existing oversight hasn’t been used to the fullest.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.